Name | Anandamide (in Tocrisolve™ 100) |
---|---|
Supplier | Tocris Bioscience |
Catalog | 1339 |
Prices | $189.00, $765.00 |
Sizes | 10 mg, 50 mg |
Function Type | Agonist |
Cas Number | 94421-68-8 |
Chemical Name | N-(2-Hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide |
Formula | C22H37NO2 |
Molecular Weight | 347.54 |
Description | Endogenous cannabinoid and vanilloid receptor agonist, in water-soluble emulsion (for details see Tocrisolve TM 100 , Cat. No. 1684). K i values are 89 and 371 nM for CB 1 and CB 2 receptors respectively; EC 50 values are 18, 31 and 27 nM at GPR55, CB 1 and CB 2 respectively; pK i = 5.68 for rVR1. Also blocks TNF- α -induced NF-kB activation via direct inhibition of IKK. Also available as the pure oil dissolved in ethanol ( Anandamine , Cat. No. 1339). Tocrisolve Control (Cat. No. 1684) also available. |
Supplier Page | Shop |
Pertwee RG. Curr Med Chem. 1999 Aug;6(8):635-64.
Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG. Br J Pharmacol. 2001 Feb;132(3):631-40.
Gardiner SM, March JE, Kemp PA, Bennett T. Br J Pharmacol. 2002 Apr;135(8):1889-96.
Kagaya M, Lamb J, Robbins J, Page CP, Spina D. Br J Pharmacol. 2002 Sep;137(1):39-48.
Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E. Mol Pharmacol. 2003 Feb;63(2):429-38.
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. Br J Pharmacol. 2007 Dec;152(7):1092-101. Epub 2007 Sep 17.